In February 2016, Dr. Holger Adelmann was appointed Senior Vice President and Managing Director for DIA Europe, Middle East and Africa (DIA EMEA). Dr. Adelmann previously served as the Global Head of Merck Serono’s Clinical Pharmacology and Clinical Biomarker operations, where he re-engineered the Clinical Biomarker and Companion Diagnostics business to better align with the company’s upcoming portfolio. In this podcast from DIA’s flagship offering in Europe, our 28th Annual EuroMeeting, Holge...
In February 2016, Dr. Holger Adelmann was appointed Senior Vice President and Managing Director for DIA Europe, Middle East and Africa (DIA EMEA). Dr. Adelmann previously served as the Global Head of Merck Serono’s Clinical Pharmacology and Clinical Biomarker operations, where he re-engineered the Clinical Biomarker and Companion Diagnostics business to better align with the company’s upcoming portfolio. In this podcast from DIA’s flagship offering in Europe, our 28th Annual EuroMeeting, Holger and DIA Global Forum Deputy Editor Dr. Alberto Grignolo discuss the progress and promise of DIA EMEA.
View more